Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
46,691,176
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
57,424,056
-
Shares change
-
+143,210
-
Total reported value, excl. options
-
$620,702,412
-
Value change
-
-$40,136,853
-
Put/Call ratio
-
81%
-
Number of buys
-
73
-
Number of sells
-
68
-
Price
-
$10.81
Institutional Holders of 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) as of Q3 2024
As of 30 Sep 2024 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) had 167 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 57,424,056 shares of stock of the company.
Largest 10 holders included BVF INC/IL, RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., VR Adviser, LLC, Deep Track Capital, LP, GOLDMAN SACHS GROUP INC, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, STATE STREET CORP, and MORGAN STANLEY.
This table shows 167 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.